Therapeutic blockade of calcineurin/NFAT pathways not only induced apoptosis of melanoma cells, it also enhanced the antitumor effects of target-specific drugs, such as MEK or BRAF inhibitors [53]. The gene discussed is BRAF; the disease is melanoma.